Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...

Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced ...

Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...

Shift Bioscience (Shift), a biotech company using an AI-powered virtual cell to fight age-driven diseases, appointed Lord ...

Here is a brief rundown of some coming entertainment options in Northeast Ohio. Make submissions for consideration via email to entertainment@morningjournal.com or entertainment@news-herald.com. You ...

Wedbush analyst Daniel Ives echoed this point ... the Google report appeared to ease investor worries about Big Tech. "Is Dr. Google what the market needed?" Bernstein analyst Mark Shmulik ...

Watching the tech sector for Wedbush, analyst Daniel Ives outlines the sheer scale of the AI Revolution that’s upon us. “Over the last few years, we have discussed the AI Revolution constantly ...

The announcement of the 90-day tariff pause with China turned into a boon for tech stocks, as the indexes spiked higher. One ...

Wedbush Securities' Global Head of Technology Research, Daniel Ives, has raised Tesla Inc.‘s TSLA price target to $350 after Elon Musk announced “significantly” reducing his time allocation ...

Tesla (NASDAQ:TSLA) is looking to shake off boardroom drama with Wedbush's Daniel Ives says the leadership dust has finally settled and Elon Musk remains Tesla's undisputed CEO as the automaker ...